Revisiting potential druggable targets against SARS‐CoV ‐2 and repurposing therapeutics under preclinical study and clinical trials: A comprehensive review-Reference-Cited by-同舟云学术

Revisiting potential druggable targets against SARS‐CoV ‐2 and repurposing therapeutics under preclinical study and clinical trials: A comprehensive review

Published:2020-07-06 Issue:8 Volume:81 Page:919-941
ISSN:0272-4391
Container-title:Drug Development Research
language:en
Short-container-title:Drug Dev Res

Author:

Sohag Abdullah Al Mamun¹,Hannan Md Abdul¹²³^ORCID,Rahman Sadaqur⁴,Hossain Motaher⁵,Hasan Mahmudul⁶,Khan Md Kawsar⁴⁷,Khatun Amena⁸,Dash Raju²,Uddin Md Jamal³⁹

Affiliation:

1. Department of Biochemistry and Molecular Biology Bangladesh Agricultural University Mymensingh 2202 Bangladesh

2. Department of Anatomy Dongguk University College of Medicine Gyeongju 38066 South Korea

3. ABEx Bio‐Research Center East Azampur, Dhaka Bangladesh

4. Department of Biochemistry and Molecular Biology Shahjalal University of Science and Technology Sylhet Bangladesh

5. Department of Biological Sciences The University of Alabama Tuscaloosa Alabama USA

6. Department of Pharmaceuticals and Industrial Biotechnology Sylhet Agricultural University Sylhet Bangladesh

7. Department of Biological Sciences Macquarie University Sydney New South Wales Australia

8. Northern International Medical College Hospital Dhaka Bangladesh

9. Graduate School of Pharmaceutical Sciences, College of Pharmacy Ewha Womans University Seoul Republic of Korea

Funder

Ministry of Science, ICT and Future Planning

National Research Foundation of Korea

Publisher

Wiley

Subject

Drug Discovery

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1002/ddr.21709

Reference172 articles.

1. Natural Killer Cells: Development, Maturation, and Clinical Utilization

2. Evaluation of SSYA10-001 as a Replication Inhibitor of Severe Acute Respiratory Syndrome, Mouse Hepatitis, and Middle East Respiratory Syndrome Coronaviruses

3. SARS-CoV-2 Vaccines: Status Report

4. The proximal origin of SARS-CoV-2

5. Global patterns in coronavirus diversity

Cited by 35 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Structural, dynamic behaviour, in-vitro and computational investigations of Schiff’s bases of 1,3-diphenyl urea derivatives against SARS-CoV-2 spike protein;Scientific Reports;2024-06-01

2. Unravelling Insights into the Evolution and Management of SARS-CoV-2;BioMedInformatics;2024-02-03

3. Assessing the Potential Contribution of In Silico Studies in Discovering Drug Candidates That Interact with Various SARS-CoV-2 Receptors;International Journal of Molecular Sciences;2023-10-24

4. Non-Specific Means of Medical Protection Against COVID-19;Antibiotics and Chemotherapy;2023-10-20

5. Clinical Trials of Mesenchymal Stem Cells for the Treatment of COVID 19;Current Stem Cell Research & Therapy;2023-10-05